FPH.AX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 08:10):

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide...

Stats
Dagens volum	194 391
Gjennomsnittsvolum	305 394
Markedsverdi	14.86B
EPS	$0.125 ( 2020-09-29 )
Neste inntjeningsdato	( $0 ) 2024-05-28
Last Dividend	$0.212 ( 2023-06-26 )
Next Dividend	$0 ( N/A )
P/E	62.07
ATR14	$0.0120 (0.05%)

Volum Korrelasjon

Lang: 0.18 (neutral)

Kort: 0.00 (neutral)

Signal:(47.356) Neutral

Fisher & Paykel Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fisher & Paykel Korrelasjon - Valuta/Råvare

-0.10
( neutral )

0.12
( neutral )

0.00
( neutral )

0.06
( neutral )

0.84
( strong )

-0.41
( neutral )

Fisher & Paykel Økonomi

Annual	2023
Omsetning:	$1.49B
Bruttogevinst:	$885.34M (59.54 %)
EPS:	$0.410

FY	2023
Omsetning:	$1.49B
Bruttogevinst:	$885.34M (59.54 %)
EPS:	$0.410

FY	2022
Omsetning:	$1.52B
Bruttogevinst:	$938.68M (61.70 %)
EPS:	$0.610

FY	2021
Omsetning:	$1.95B
Bruttogevinst:	$1.22B (62.76 %)
EPS:	$0.915

Financial Reports:

No articles found.

Fisher & Paykel Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.165 (N/A)	$0 (N/A)	$0.212 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Fisher & Paykel Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.73 - Stable (34.54%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0500	2002-06-07
Last Dividend	$0.212	2023-06-26
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	42	--
Total Paid Out	$3.24	--
Avg. Dividend % Per Year	0.00%	--
Score	4.12	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.73
Div. Directional Score	9.00	--

Next Divdend (Est)
(2024-10-21)

$0.221 Estimate 3.71 %

Dividend Stability

0.30 Very Poor

Dividend Score

4.12

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SPK.AX	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%
COF.AX	Ex Dividend Junior	2023-09-28	Quarterly	0.00%
MVF.AX	Ex Dividend Junior	2023-09-07	Annually	0.00%
WAM.AX	Ex Dividend Knight	2023-10-17	Semi-Annually	0.00%
EGG.AX	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%
PBH.AX	No Dividend Player	2023-09-06	Insufficient data to determine frequency	0.00%
ALL.AX	Ex Dividend Knight	2023-05-25	Annually	0.00%
GOZ.AX	Ex Dividend Junior	2023-06-29	Semi-Annually	0.00%
REH.AX	Ex Dividend Knight	2023-10-10	Semi-Annually	0.00%
BOQ.AX	Ex Dividend Junior	2023-05-10	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.153	1.500	6.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.110	1.200	6.34	7.61	[0 - 0.3]
returnOnEquityTTM	0.144	1.500	9.51	10.00	[0.1 - 1]
payoutRatioTTM	0.563	-1.000	4.37	-4.37	[0 - 1]
currentRatioTTM	2.54	0.800	2.29	1.830	[1 - 3]
quickRatioTTM	1.059	0.800	8.48	6.78	[0.8 - 2.5]
cashRatioTTM	0.246	1.500	9.75	10.00	[0.2 - 2]
debtRatioTTM	0.128	-1.500	7.87	-10.00	[0 - 0.6]
interestCoverageTTM	26.34	1.000	1.354	1.354	[3 - 30]
operatingCashFlowPerShareTTM	0.632	2.00	9.79	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0505	2.00	9.97	10.00	[0 - 20]
debtEquityRatioTTM	0.174	-1.500	9.30	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.601	1.000	3.32	3.32	[0.2 - 0.8]
operatingProfitMarginTTM	0.219	1.000	7.63	7.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.288	1.000	3.95	3.95	[0.2 - 2]
assetTurnoverTTM	0.717	0.800	8.56	6.84	[0.5 - 2]
Total Score				11.27

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.74	1.000	3.97	0	[1 - 100]
returnOnEquityTTM	0.144	2.50	9.68	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0505	2.00	9.98	10.00	[0 - 30]
dividendYielPercentageTTM	1.305	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.632	2.00	9.79	10.00	[0 - 30]
payoutRatioTTM	0.563	1.500	4.37	-4.37	[0 - 1]
pegRatioTTM	0.810	1.500	7.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.230	1.000	6.75	0	[0.1 - 0.5]
Total Score				6.73

Fisher & Paykel

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.